IN-02

N/A

Report date: 2025/05/27 11:03:00

Base Information

Drug NameIN-02
Drug Alias NameIN 02IN-02
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIn3Bio Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIn3Bio Ltd
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A